Skip to main content
Erschienen in: Clinical Rheumatology 5/2012

01.05.2012 | Case Based Review

Different clinical presentation of the hyperimmunoglobulin D syndrome (HIDS) (four cases from Turkey)

verfasst von: Dıdem Arslan Tas, Suzan Dınkcı, Eren Erken

Erschienen in: Clinical Rheumatology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Hyperimmunoglobulin D syndrome (HIDS) is one of the autoinflammatory syndromes which are characterized by febrile attacks. Duration and frequency of the febrile attacks, as well as typical organ involvements vary greatly. Recently, it is possible to reach more reliable data by the possibilities that are opened up by molecular genetics in order to highlight the aetiopathogenesis of this group of diseases. Typical patients with HIDS have an onset of disease in the first year of life. Here, we report four Turkish HIDS cases; three of whom, the symptoms started at a later age. The diagnoses were made by relevant clinical symptoms along with MVK mutations detected by DNA sequencing method. As summarised in this article, HIDS could be presented with a broad spectrum of symptoms. Although most of the HIDS patients are reported from Europe and especially Dutch ancestry, case reports are presented from all over the world. For this reason, HIDS should be kept in mind for the differential diagnosis of periodic fever syndromes or before accepting an FMF patient as colchichine resistant. We suppose that the phenomenon of “later-onset HIDS” should shed light into unresolved clinical problems of patients with periodic fever. Especially in countries that FMF is more frequent such as Turkey, even though the symptoms start later than classic cases, HIDS should be kept in mind for differential diagnosis of periodic fever syndromes.
Literatur
1.
Zurück zum Zitat van der Meer JW, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, van Furth R (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1(8386):1087–1090PubMedCrossRef van der Meer JW, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, van Furth R (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1(8386):1087–1090PubMedCrossRef
2.
Zurück zum Zitat Simon A, Cuisset L, Franccoise-Vincent M et al (2001) Molecular analysis of the mevalonate kinasegene in a cohort of patients with the Hyper-IgD and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med 135:338–343PubMed Simon A, Cuisset L, Franccoise-Vincent M et al (2001) Molecular analysis of the mevalonate kinasegene in a cohort of patients with the Hyper-IgD and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med 135:338–343PubMed
3.
Zurück zum Zitat Prietsch V, Mayatepek E, Krastel H et al (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 111:258–261PubMedCrossRef Prietsch V, Mayatepek E, Krastel H et al (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 111:258–261PubMedCrossRef
4.
Zurück zum Zitat Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G, Ravet N (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46(10):1597–1600CrossRef Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G, Ravet N (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46(10):1597–1600CrossRef
5.
Zurück zum Zitat van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87(6):301–310CrossRef van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87(6):301–310CrossRef
6.
Zurück zum Zitat Steichen O, van der Hilst J, Simon A, Cuisset L, Grateau G (2009) A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol 36(8):1677–1681PubMedCrossRef Steichen O, van der Hilst J, Simon A, Cuisset L, Grateau G (2009) A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol 36(8):1677–1681PubMedCrossRef
7.
Zurück zum Zitat Shendi HM, Walsh D, Edgar JD (2009) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int, Dec 18 Shendi HM, Walsh D, Edgar JD (2009) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int, Dec 18
8.
Zurück zum Zitat Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73:133–144 Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73:133–144
9.
Zurück zum Zitat Frenkel J, Houten SM, Waterham HR et al (2000) Mevalonate kinase deficiency and Dutch type periodic fever. Clin Exp Rheumatol 18:525–532PubMed Frenkel J, Houten SM, Waterham HR et al (2000) Mevalonate kinase deficiency and Dutch type periodic fever. Clin Exp Rheumatol 18:525–532PubMed
10.
Zurück zum Zitat Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48(3) Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48(3)
11.
Zurück zum Zitat Topaloğlu R, Saatçi U (1991) Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean. Postgrad Med J 67(787):490–491PubMedCrossRef Topaloğlu R, Saatçi U (1991) Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean. Postgrad Med J 67(787):490–491PubMedCrossRef
12.
Zurück zum Zitat Coban E, Terzioğlu E (2004) A patient with hyper-IgD syndrome in Antalya, Turkey. Clin Rheumatol 23(2):177–178PubMedCrossRef Coban E, Terzioğlu E (2004) A patient with hyper-IgD syndrome in Antalya, Turkey. Clin Rheumatol 23(2):177–178PubMedCrossRef
13.
Zurück zum Zitat Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S (2007) A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26(10):1757–1759PubMedCrossRef Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S (2007) A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26(10):1757–1759PubMedCrossRef
14.
Zurück zum Zitat Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27(10):1317–1320PubMedCrossRef Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27(10):1317–1320PubMedCrossRef
15.
Zurück zum Zitat Hammoudeh M (2005) Hyperimmunoglobulinemia D syndrome in an Arab child. Clin Rheumatol 24(1):92–94PubMedCrossRef Hammoudeh M (2005) Hyperimmunoglobulinemia D syndrome in an Arab child. Clin Rheumatol 24(1):92–94PubMedCrossRef
16.
Zurück zum Zitat D'Osualdo A, Picco P, Caroli F, Gattorno M, Giacchino R, Fortini P, Corona F, Tommasini A, Salvi G, Specchia F, Obici L, Meini A, Ricci A, Seri M, Ravazzolo R, Martini A, Ceccherini I (2005) MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever. Eur J Hum Genet 13(3):314–320PubMedCrossRef D'Osualdo A, Picco P, Caroli F, Gattorno M, Giacchino R, Fortini P, Corona F, Tommasini A, Salvi G, Specchia F, Obici L, Meini A, Ricci A, Seri M, Ravazzolo R, Martini A, Ceccherini I (2005) MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever. Eur J Hum Genet 13(3):314–320PubMedCrossRef
17.
Zurück zum Zitat Abreu TT (2004) Periodic fever: the first Portuguese case-report of hyper-IgD syndrome (HIDS). Acta Med Port 17(5):391–394PubMed Abreu TT (2004) Periodic fever: the first Portuguese case-report of hyper-IgD syndrome (HIDS). Acta Med Port 17(5):391–394PubMed
18.
Zurück zum Zitat Naruto T, Nakagishi Y, Mori M, Miyamae T, Imagawa T, Yokota S (2009) Hyper-IgD syndrome with novel mutation in a Japanese girl. Mod Rheumatol 19(1):96–99PubMedCrossRef Naruto T, Nakagishi Y, Mori M, Miyamae T, Imagawa T, Yokota S (2009) Hyper-IgD syndrome with novel mutation in a Japanese girl. Mod Rheumatol 19(1):96–99PubMedCrossRef
Metadaten
Titel
Different clinical presentation of the hyperimmunoglobulin D syndrome (HIDS) (four cases from Turkey)
verfasst von
Dıdem Arslan Tas
Suzan Dınkcı
Eren Erken
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 5/2012
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1932-x

Weitere Artikel der Ausgabe 5/2012

Clinical Rheumatology 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.